For STAT, Sheila Kaplan reports how the pharmaceutical industry is lobbying presidential candidates and making major contributions, even to candidates who have criticized the industry. “Money is absolutely key for access, that’s the harsh reality,” said Wright H. Andrews Jr., a longtime lobbyist and former head of the American League of Lobbyists. “They are still going to make donations — directly, indirectly — or they will hire people who have.”
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.